Daniël Jan Ellens
President chez Elkerim GmbH
Provenance du réseau au premier degré de Daniël Jan Ellens
Entité | Type d'entité | Industrie | |
---|---|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
13
| Subsidiary | Investment Managers | 13 |
Rhein Biotech NV
Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Daniël Jan Ellens via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Consultant / Advisor Director of Finance/CFO Private Equity Investor Private Equity Investor General Counsel | |
Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Chairman | |
University of Twente | College/University | Corporate Officer/Principal Graduate Degree | |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
BMEYE BV
BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director of Finance/CFO Director/Board Member | |
Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
LSP Advisory BV
LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Association of European Science & Technology Transfer | Founder | ||
Coöperatief LSP IV UA | Investment Managers | Director/Board Member | |
Semaia Pharmaceuticals | Chief Executive Officer | ||
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Founder | |
SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
MERUS N.V. | Biotechnology | Director/Board Member | |
University of Utrecht | College/University | Graduate Degree | |
Gilde Healthcare Partners BV
Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge. | Investment Managers | Private Equity Investor | |
Nobi NV
Nobi NV Medical/Nursing ServicesHealth Services Nobi NV operates as an elderly and residential care center. The company is based in Antwerp, Belgium. The Belgian company was founded by Roeland Pelgrims, Bert de Haes. Roeland Pelgrims has been the CEO since incorporation. | Medical/Nursing Services | Director/Board Member | |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Lumeon Ltd.
Lumeon Ltd. Packaged SoftwareTechnology Services Lumeon Ltd. operates as a digital health company. It offers cloud-based management platform for outpatient care providers including doctors, ophthalmologists, and physiotherapists. The firm?s platform offers pre-operative and discharge readiness, chronic disease, post-acute care, lifestyle coaching, and imaging optimization solutions. The company was founded by Robbie M. Hughes on August 4, 2005 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
Stichting De Weijerhorst
Stichting De Weijerhorst Investment Trusts/Mutual FundsMiscellaneous Stichting De Weijerhorst provides welfare and pension funds. The company is headquartered in Maastricht, the Netherlands. | Investment Trusts/Mutual Funds | Director/Board Member | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member | |
Radboud University Nijmegen | College/University | Graduate Degree | |
BNP Paribas Fortis (New York Branch)
BNP Paribas Fortis (New York Branch) Regional BanksFinance Part of TEB Holding AS, BNP Paribas Fortis (New York Branch) is a commercial bank. The company is based in New York, NY. | Regional Banks | Corporate Officer/Principal | |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director of Finance/CFO | |
PURETECH HEALTH PLC | Biotechnology | Director of Finance/CFO | |
Lumeon, Inc. | Director/Board Member | ||
Health Economics Privak II NV
Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member | |
KARA THER | Pharmaceuticals: Major | Director/Board Member | |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Director/Board Member | |
University of Tilburg | College/University | Undergraduate Degree | |
Evommune, Inc.
Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin | |
Vrije Universiteit Amsterdam | College/University | Graduate Degree | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member | |
FoRx Therapeutics AG
FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Pays-Bas | 21 |
Etats-Unis | 11 |
Belgique | 10 |
Suisse | 4 |
France | 4 |
Sectorielle
Health Technology | 22 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 4 |
Electronic Technology | 3 |
Opérationnelle
Director/Board Member | 89 |
Corporate Officer/Principal | 18 |
Private Equity Investor | 17 |
Director of Finance/CFO | 16 |
Graduate Degree | 10 |
Relations les plus connectées
Insiders | |
---|---|
Jörg Neermann | 34 |
Rudy Dekeyser | 29 |
John Paul de Koning | 21 |
Jan Vesseur | 16 |
Vincent Brichard | 15 |
Clemens A. van Blitterswijk | 12 |
Joep Muijrers | 10 |
Felice Verduyn-van Weegen | 9 |
Geraldine O'Keeffe | 8 |
Harry Relouw | 4 |
Merijn Klaassen | 4 |
Bas Vaessen | 4 |
Risto Miettunen | 3 |
Frits van der Have | 2 |
- Bourse
- Insiders
- Daniël Jan Ellens
- Connexions Sociétés